Glycated Albumin
GA
Description
"Glycated Albumin" test measures the amount of glucose attached to albumin in your blood, providing a snapshot of blood sugar control over the past 2–3 weeks. It’s especially useful when A1C results are unreliable due to anemia or kidney disease. Elevated levels may indicate poor glucose regulation, while normal levels suggest effective management. Doctors use this test to track short-term treatment changes. Ongoing monitoring supports more responsive diabetes care and helps prevent complications.
Category
Glycoproteins, Proteins
Procedure
Invasive
Sample Type
Blood – Serum
Units
Percentage
Procedure Category
Blood Draw
Test Group
Complete Blood Sugar Group
Test Group Description
Complete Blood Sugar Group: This expanded group includes a more comprehensive set of tests, offering a thorough evaluation of diverse facets of blood sugar levels for a more detailed understanding of metabolic health.
Optimal Range
For All Individuals:
Conventional Unit: 10.0–13.5%
SI Unit: Not Applicable
Normal Range
For All Individuals:
Conventional Unit: 11.9–15.8%
SI Unit: Not Applicable
Results That Differ From The Norm (Direct and Indirect Causes)
Increased levels may indicate:
Acute cerebral infarction (Sudden blockage of an artery in the brain)
Azotemia (Elevated levels of nitrogen-containing compounds in the blood)
Cirrhosis (Chronic liver damage)
Cerebrovascular disease (Disorders that affect blood vessels and blood supply to the brain)
Coronary heart disease (Narrowing of the coronary arter...
Key Reasons For Testing
Diagnosis and Monitoring of Diabetes: Reflects short-term changes in blood glucose over two to three weeks, aiding in the diagnosis and management of diabetes.
Assessment of Glycemic Control: Provides a snapshot of recent glycemic trends, complementing HbA1c for immediate evaluation.
Prediction of Complications: Elevated levels are linked to risks of cardiovascular, kidney, nerve, and eye diseases.
Personalized Treatment Goals: Guides tailored glycemic targets and therapy adjustments.
Treatment Efficacy Monitoring: Tracks response to interventions, optimizing diabetes management.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J.2010;57(9):751-762.
[2] Inaba M, Okuno S, Kumeda Y, et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in hemodialysis patients with diabetes. Nephrol Dial Transplant. 2007;22(4):984-989.
[3] Furusyo N, Hayashi J. Glycated albumin and diabetes mellitus. Biochim Biophys Acta. 2013;1830(12):5509-5514.
[4] Yoshiuchi K, Matsuhisa M, Katakami N, et al. Glycated albumin is a better indicator of glycemic control than glycated hemoglobin values in uncontrolled diabetes. Diabetes Care. 2008;31(6):920-923.
[5] Kohzuma T, Koga M. Glycated albumin: clinical usefulness. Clin Chim Acta. 2017;467:63-70.
[6] Wu WC, Ma WY, Wei JN, et al. Serum glycated albumin to guide the diagnosis of diabetes mellitus. PLoS One.2016;11(1).
[7] Sumner AE, Thoreson CK, O’Connor MY, et al. Detection of abnormal glucose tolerance in Africans is improved by combining hemoglobin A1C with glycated albumin. Diabetes Care. 2015;38(2):213-219.
[8] Koga M, Matsumoto S, Saito H, Kasayama S. Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocr J. 2006;53(3):387-391.
[9] Nathan DM, McGee P, Steffes MW, et al. Relationship of glycated albumin to blood glucose and glycated hemoglobin (A1c) values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes.2014;63(1):282-290.
[10] Hsu P, Ma WY, Wei JN, et al. Serum glycated albumin predicts coronary artery disease better than HbA1c in diabetes. Medicine (Baltimore). 2015;94(43).
[11] Ai M, Otokozawa S, Asztalos BF, et al. Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham Offspring Study. Atherosclerosis. 2011;217(2):543-548.
[12] Wang Z, Xing G, Zhang L. Glycated albumin level is significantly decreased in patients suffering nephrotic syndrome. Prog Mol Biol Transl Sci. 2019;162:307-319.
[13] Ribeiro RT, Macedo MP, Raposo JF. HbA1c, Fructosamine, and Glycated Albumin in the Detection of Dysglycaemic Conditions. Curr Diabetes Rev. 2016;12(1):14-19.